Linearized p-eGFP (plasmid-enhanced green fluorescent protein) or p-hFSH (plasmid human FSH) sequences with the corresponding restriction enzyme were lipofected into sperm genomic DNA. Sperm transfected with p-eGFP were used for artificial insemination in hens, and in 17 out of 19 of the resultant chicks, the exogenous DNA was detected in their lymphocytes as determined by PCR and expressed in tissues as determined by (a) PCR, (b) specific emission of green fluorescence by the eGFP, and (c) Southern blot analysis. A complete homology was found between the Aequorea Victoria eGFP DNA and a 313-bp PCR product of extracted DNA from chick blood cells. Following insemination with sperm lipofected with phFSH, transgenic offspring were obtained for two generations as determined by detection of the transgene for human FSH (PCR) and expression of the gene (RT-PCR and quantitative real-time PCR) and the presence of the protein in blood (radioimmunoassay). Data demonstrate that lipofection of plasmid DNA with restriction enzyme is a highly efficient method for the production of transfected sperm to produce transgenic offspring by direct artificial insemination.
INTRODUCTION
Mass production of transgenic chickens would have two major applications. Transgenic chickens carrying specific marker genes would greatly facilitate studies of vertebrate developmental biology because the chick is a major embryological model, and egg-laying transgenic chickens could be an efficient bioreactor producing valuable pharmaceutical proteins. In addition, transgenic chickens expressing siRNA to emerging viruses could be a major contribution to animal health protection.
The use of DNA-lipofected sperm has the advantage over micromanipulation for producing transgenic animals as it is a simple procedure and there is no trauma to the oocytes [for reviews see [1] [2] [3] [4] . Lipofected sperm are of particular interest in avian species where micromanipulation of the oocyte is not feasible. Although some success has been reported for DNAlipofected sperm in cattle [5, 6] , early attempts to use the technique in chickens were not successful [7] . To increase the efficacy of the transfection, restriction enzyme-mediated insertion (REMI) can be used to linearize the DNA and generate cohesive ends. The corresponding restriction enzyme is then thought to cut the genomic DNA at sites that enable the exogenous DNA to integrate via its matching cohesive ends [8, 9] . REMI has been used to insert exogenous DNA into nuclei isolated from Xenopus laevis (African clawed toad) sperm [10] . The isolated nuclei were then manually injected into Xenopus oocytes to produce transgenic embryos.
We hypothesized that avian DNA-transfected sperm produced by lipofection and REMI would be a highly efficient procedure to produce sperm that carry the transgene. The transformed sperm could then be used in artificial insemination to produce transgenic offspring.
MATERIALS AND METHODS

Animals
Chickens were commercial layers (Agricultural Research Organization, Bet Dagan, Israel). All procedures described where animals were used were approved by the Animal Welfare Committee of the Kimron Veterinary Institute. Chickens were maintained under constant veterinary care.
Preparation of p-eGFP
The plasmid for enhanced green fluorescent protein (p-eGFP) (Clontech, Palo Alto, CA; GenBank Accession #U57609) is a modified GFP that expresses eGFP with a double amino acid substitution (Phe-64 for Leu and Ser-65 for Thy). This 238-amino-acid protein absorbs blue light and emits green light after excitation of an intrinsic chromatophore. The eGFP structural gene was expressed under control of the cytomegalovirus (CMV) promoter. p-eGFP was completely linearized by incubating the DNA with Not I restriction enzyme (0.5 units/lg p-eGFP) at 378C for 4 h.
Sperm Collection
Semen was collected from five roosters by massage and pooled (3-4 ml). Pools of sperm, each consisting of sperm from five roosters, were then used for artificial insemination (AI).
Sperm Lipofection with eGFP
Liposomes were prepared as described by Felgner et al. [11] using LipofectAMINE from BRL-Life technologies according to the manufacturer's instructions. Three solutions were prepared: solution A, 10 lg Not I linearized p-eGFP/100 ll Optimem I (Gibco-BRL, Paisley, Scotland); solution B, 10 lg LipofectAMINE/100 ll Optimem I; and solution C, 100 units of Not I restriction enzyme/100 ll Optimem I. Solutions A and B (100 ll each) were combined in wells (24-well tissue culture plate; Costar, Corning, NY) for 1 h at ambient temperature to enable DNA-liposome complex to form. Solutions C and B (100 ll each) were similarly combined and incubated to enable the restriction enzyme-liposome complex to form. After the incubation, the two resultant complexes were combined with a suspension of sperm cells (600 ll semen containing 10 9 cells) for a total volume of 1000 ll, followed by gentle mixing and a 2-h incubation at ambient temperature prior to AI.
Production of Transgenic Chickens Expressing eGFP
Avian sperm (0.1 ml) lipofected with Not I linearized p-eGFP and Not I were used for AI of each hen. Eggs were collected for 6 days and hatched (hatch rate 95%). Altogether, 89 chicks were hatched. At the age of 1 mo, blood samples were taken from 19 randomly selected chicks.
Blood Cell DNA Extraction for eGFP
Cell nuclei were first isolated from 5 ml of whole blood by the addition of two volumes of cold lysis buffer (320 mM sucrose, 1 mM Tris-HCL, 5 mM MgCl 2 , 1% Triton X-100; pH 7.5) mixed by inversion and held at ambient temperature for 1 min or until the solution cleared, indicating hemolysis [12] . Cell nuclei were sedimented by centrifugation for 2 min at 5000 3 g, and the supernatant was decanted. The nuclear pellet was washed once with two volumes of lysis buffer followed by centrifugation for 2 min at 5000 3 g. The resulting nuclear pellet was dissolved in 1 ml of DNA zol (Genomic DNA isolation regent; Molecular Research Center Inc.
[MRC], Cincinnati, OH) by shaking or repeated pipetting (2 ml DNA zol/5 ml of blood). The nuclear lysate was held at ambient temperature for 5 min, and the DNA was precipitated with 0.5 volumes of ethanol and held at ambient temperature for 2 min. DNA was sedimented at 5000 3 g for 2 min and washed once with 95% ethanol, and the wash was removed by decanting. The DNA pellet was then solubilized in water.
PCR for eGFP in Avian Blood DNA Total blood DNA was used as a template in the PCR reaction using a pair of primers corresponding to the eGFP sequence. The primers, 20-mer each, were selected using the OLIGO program (Oligo 5.0 RT primer analysis software; Molecular Biology Insights, Cascade, CO). The forward primer corresponded to positions 702-721 (5 0 -ACCGGGGTGGTGCCCATCCT-3 0 ). The reverse primer oligonucleotide was complementary to position 996-1015 (5 0 -TTCACCTCGGCGGGGTCTT-3 0 ). The predicted size of the PCR product was 313 bp. The reaction was allowed to proceed for 35 cycles using two units of Taq DNA polymerase (recombinant; MBI Fermentas, Vilna, Lithuania) and 200 pmol of each primer. The cycling parameters of the PCR were 988C for 20 sec, 608C for 45 sec, and 728C for 45 sec. After amplification the samples were separated on 1% agarose, stained with ethidium bromide, and photographed under UV light.
Flow Cytometry
White blood cells were separated by slow centrifugation (50 3 g for 10 min) and analyzed within 3 h after collection by a FACScan flow cytometer (Becton Dickenson Immuncytometry system; Becton Dickenson, San Jose, CA). The laser emitter was set at a wavelength of 520 nm (green fluorescence). The FL1 emission channel (normally used to detect fluorescein isothiocyanate [FITC] ) was used to monitor eGFP fluorescence. The number of white blood cells in each sample was determined by a Coulter cell counter (21 model; Counter Electronic, Luton, UK). The final volume of the samples was 1 ml in PBS, and the minimal concentration of white blood cells read was 10 000 events per sample. The control samples used were white blood cells from normal chickens. The results are given as a percentage of positive cells expressing emission of green light.
Southern Blot Analysis for eGFP
Total DNA from blood cells was digested and subjected to electrophoresis through a 1.5% agarose gel and transferred by capillary blotting to Hybond-C membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK). The PCR product fragments of 313 bp for eGFP were used to generate biotinylated probes using random primer biotin labeling of DNA for DNA chemiluminescence (NEBlot Phototype Kit; New England Biolabs, Beverly, MA) according to the manufacturer's instructions. The membranes were hybridized overnight at 658C with our probe in 0.5 M sodium phosphate (pH 7.2), 7% SDS, and 100 lg/ml denatured herring sperm DNA (Boehringer, East Sussex, UK). Membranes were washed at high stringency (0.13 standard saline citrate and 0.1% SDS, 658C) and subjected to chemiluminescence development and detection on x-ray film (RX; FujiFilm, Tokyo, Japan).
Preparation of p-hFSH
Genes encoding the human common gonadotropin alpha subunit (accession no. nm_000735) and follicle stimulating hormone (FSH)-specific beta subunit (accession no. NM_000510) and leader sequences were designed from sequences from GenBank and the construct was synthesized by Operon Technologies, Almedia, CA. The chemically synthesized gene was inserted into pTarget expression vector under the CMV promoter. The forward primer (25 mer) corresponded to positions 247-272 (5 0 -CTTGCCACCTGACCAACAT-TACCA T-3 0 ). The reverse primer oligonucleotide (24 mer) was complementary to positions 807-831 (5 0 -CACGTTCTTCTGCACCAGCATAGT-3 0 ). The predicted size of the PCR product was 584 bp.
To determine that the synthesized construct of a combination of the two gene subunits were active and could produce hFSH, the construct was tested in cell culture. This construct was lipofected in Chinese hamster ovarian cells as described in Xiuzhu [13] , and the resulting expression was measured by radioimmunoassay (RIA) (MEDICORP, Montreal, Canada; Cat. No. KTSP-4951), immunofluorescence using specific antibody against hFSH (National Hormone & Peptide Program, NHPP, Torrance, CA) and FITC-conjugated goat anti-rabbit secondary antibody.
Sperm Lipofection with p-hFSH
The plasmid human FSH (p-hFSH) was lipofected into the chicken sperm using a similar protocol as for the eGFP. Three solutions were prepared: solution A, p-hFSH (10 lg DNA)/50 ll Optimem I); solution B, 10 lg LipofectAMINE/50 ll Optimem I; and solution C, 50 units of BgII restriction enzyme/50 ll Optimem I. Solutions A and B (100 ll each) were combined in wells for 1 h at ambient temperature to enable DNA-liposome complex to form. Solutions C and B (100 ll each) were similarly combined and incubated to enable the restriction enzyme-liposome complex to form. After the incubation, the two resultant complexes were combined with a suspension of sperm cells (600 ll semen containing 10 9 cells) for a total volume of 1000 ll, followed by gentle mixing and a 2-h incubation at ambient temperature prior to AI.
Production of Transgenic Chickens Expressing hFSH
AI was performed with 0.1 ml of the p-hFSH-lipofected sperm. Eggs were collected for 6 days and then hatched in an incubator. For the second generation (G 2 ), transgenic birds were mated and the eggs collected in a similar fashion. Normal control chicks were artificially inseminated with lipofected sperm in the absence of plasmid DNA.
Radioimmunoassay for hFSH in Chicken Blood
To determine human FSH gene expression in the chickens produced using sperm lipofected with p-hFSH, sera from two generations of transgenic chickens were analyzed using two commercial RIA kits for hFSH (Coat-acount FSH IRMA; DPC, Los Angeles, CA and MEDICORP, Montreal, Canada; Cat. No. KTSP-4951). Nontransgenic chickens of the same age were used as controls.
PCR and RT-PCR for Human FSH in Chicken Tissues
DNA or RNA was extracted from amniotic membranes, embryos that did not hatch, and from three chicks at 2-3 wk of age. PCR was used to detect the transgene. RT-PCR was used to demonstrate the expression of eGFP and human FSH mRNA in the chicken tissues. Two microliters of total RNA (200 ng) and a mix of random mRNA primers (Promega) were used. DNAse Itreated RNA was reverse transcribed by using superscript RNAse H (Promega) reverse transcriptase according to the manufacturer's instructions. The cycles were at 708C for 5 min for 2 units of reverse transcriptase and 20 units of RNAse inhibitor (Promega).
Quantitative Real-Time PCR
To determine expression of the transgene for human FSH in the chicken, we used quantitative real-time PCR in G 1 , G 2 , and G 3 chicks. RNA/DNA was extracted from tissues using Tri-reagent LS RNA/DNA isolation reagent for liquid samples (TS-120; MRC, Cincinnati, OH). Samples were first homogenized with 0.75 ml Tri reagent LS and 0.25 ml of samples, and the phases were separated with 0.1 ml BCP (1-bromo-3-chloropropane; MRC) and prepared according to the manufacturer's instructions.
For the quantitative real-time PCR, 600 ng of the extracted RNA mixture (2 ll) was used for the real-time step; the mixture contained 12.5 ll master mix TRANSGENIC CHICKENS 1047 (Applied Biosystems, Foster City, CA), 200 nM of probe, 100 nM for the control primer (28S), and 100 or 500 nM for the human FSH primers (Applied Biosystems). For 28S, forward 5 0 -GGC GAA GCC AGA GGA AACT-3 0 , reverse 5 0 -GAA CCA GCT ACT AGA TGG TTC CATT-3 0 , and probe 3 0 -AGG TCC GTA GCG GTC-5 0 VIC; for FSH, forward 5 0 -AGA GGG CTG GGT CCA TCA TA-3 0 and reverse 3 0 -TGC TTT AGA TGA TGA TGA CTC GAG T-5 0 ; Taqman probe (FAM-ATT CGG CGA AAT GAA A-MGB) (200 nM in 2 ll) in a total volume of 25 ll. The reaction conditions were: 2-min digestion step at 508C, an enzyme activation step at 958C for 10 min, denaturation at 958C for 15 sec, followed by annealing/extension at 608C (1 min) for 50 cycles. Analysis was performed using an ABI Prism 7000 (Applied Biosystems) operating program. The 28S gene in the chicken, which produces about 300 copy numbers, was used as a positive control [14] .
RNA Extraction and Reverse Transcription
RNA was extracted from tissues and blood as described above for DNA. RNA was precipitated with 0.5 ml isopropanol and washed with 1 ml 75% ethanol. The RNA was solubilized with FORMAzol (MRC).
Two microliters (200 ng RNA) of the sample were used in the RT-PCR for the detection of each transcript. The RT reaction was carried out following the manufacturer's instructions (Promega) using a mix of random primers and reverse transcriptase in a volume of 20 ll to prime the RT reaction and to produce cDNA. Tubes were first heated to 708C for 5 min to denature the secondary RNA structure, and then the RT mix was completed with 8 units of reverse transcriptase (Promega) and 20 units of RNase inhibitor (RNasine; Promega). Tubes were incubated at ambient temperature for 10 min and then at 428C for 30 min to allow the reverse transcription of RNA, followed by incubaton at 928C for 1 min to denature the RT enzyme.
RESULTS
eGFP Protein and mRNA Are Expressed in Transgenic Chickens
To demonstrate the presence of eGFP transgene in the genomic DNA, PCR was performed. Total blood cell DNA was extracted and used for PCR amplification, and a specific fragment (313 bp) of eGFP was found in the DNA of 17 out of 19 chickens, as shown in Figure 1A . This fragment was also found in testes and skin (data not shown).
To determine expression of eGFP protein in the transgenic chicks, flow cytometry was used to determine emission of green fluorescent light by white blood cells. Flow cytometric analysis indicated that, in 17 out of 19 of the chicks, 30.1 6 10.3 (SD) percent of the white blood cells exhibited the green fluorescent light characteristic of eGFP (Fig. 1B) .
RT-PCR was used to determine the expression of mRNA in the G 2 chicken blood cells (Fig. 1C) . Blood cell RNA extract from a normal chick was used as a negative control, and peGFP was used as a positive control. The PCR product of 313 bp was demonstrated in six of eight G 2 chicks.
Automated nucleotide sequencing analysis was performed for a PCR product of 313 bp compared to the nucleotides of the eGFP transgene. A complete homology was found between the Aequorea Victoria eGFP DNA and the 313-bp PCR product of chick blood cell DNA for a 313-bp fragment (data not shown).
To demonstrate that eGFP DNA was integrated in the avian genomic DNA, Southern blot analysis was performed using nine 1-yr-old transgenic chickens that were PCR amplification positive for eGFP. DNA was extracted from the blood cells; digested with three different combinations of enzymes: XbaI (Fig. 2, lane 1) , HindIII þ NotI (Fig. 2, lane 2) and HindIII þ EcoRV (Fig. 2, lane 3) ; and analyzed by Southern blot. DNA from a normal control chicken (Fig. 2 , lane 4) served as a negative control, and p-eGFP digested with NotI and HindIII was used as a positive control, as these enzymes act on the polylinkers and would free the plasmid (Fig. 2, lane 5. ) Three different fragments of about 6 kbp (n ¼ 3, lane 1), 0.7 kbp (n ¼ 2, lane 2), and 1.3 kbp (n ¼ 3, lane 3) were illuminated with our specific probe of 313 bp for eGFP. The 6-kbp fragment (Fig. 2, lane 1) consisted of eGFP and additional genomic DNA sequences (;1.3 kbp), as the maximal length of p-eGFP can not exceed 4.7 kbp (6 kbp-4.7 kbp ¼ 1.3 kbp). Production of fragments of 1.3 kbp and 0.7 kbp by combination of other enzymes was also demonstrated (Fig. 2, lanes 2 and 3) . These observations are schematically represented in the lower panel.
Expression of hFSH in Cell Culture
To determine that the method was valid for a foreign DNA other than eGFP, p-hFSH was tested. We first demonstrated that the synthesized construct of a combination of the two gene subunits is active and could produce hFSH in cell culture. The p-hFSH was lipofected in cultured Chinese hamster ovarian cells, resulting in expression and secretion of 4-12 milliunits/ml into the culture medium containing 1 million cells, as determined by a specific RIA for hFSH. The expression of hFSH in the cells was also determined by immunofluorescence using specific antibody against hFSH and secondary antibody conjugated to FITC. A specific green fluorescence appeared solely in the cytoplasm of the lipofected cells (Supplemental Figure S1 , available online at www. biolreprod.org). 
hFSH Protein Is Expressed in the Transgenic Chicks
To determine the expression of hFSH protein in the transgenic chickens, sera from transgenic and normal control chicks (n ¼ 20) was analyzed using RIA. All normal chick controls were negative for hFSH (,0.05 units/ml). In the G 1 transgenic chicks, eight out of eight were positive after 1 mo and 16 of 17 were positive for hFSH after 2 mo. No assayable hFSH was detected after 2 yr (Table 1) . Similarly, in G 2 chicks after 1.5 yr, only 7 of the 15 chickens were positive for hFSH. There were no differences in hFSH expression between the sexes.
Detection of the Transgene for Human FSH in Chicken Tissues
PCR was used to demonstrate the presence of the transgene for human FSH in the transgenic chicken. The PCR product of representative tissues is shown in Figure 3 , A and B. The specific product of 584 bp was found exclusively in the liver, skin, heart, kidney, blood, and fetal membranes (not shown) of the transgenic chickens. Sequencing of the PCR product indicated that the chicken PCR product of 584 bp was completely homologous with the hFSH sequence (Fig. 4) .
A standard curve for quantitative real-time PCR for p-hFSH and 28S mRNA extracted from chicken blood is shown in Figure 5A . The cycle number where sample amplification curves started rising increased linearly with dilution. The curves for the two genes were parallel, and the copy number of human FSH was about 1/10 of that of the housekeeping gene, 28S. Similar curves were obtained using serial dilutions of blood RNA extract (slope À3.27; intercept 32.8; R 2 ¼ 0.99). The copy number of the human FSH increased in the G 2 transgenic crosses (blood, liver) compared with G 1 (blood; Fig. 5B ). When tissue (liver) from G 1 (n ¼ 3), G 2 , and G 3 chickens (two each) were compared using quantitative realtime PCR, the copy number was apparently higher in each succeeding generation (Ct [threshold cycle] ¼ 15.5, 12.5, 5.5 successively for G 1 , G 2 , G 3 ).
The human FSH transgene was also expressed in the transgenic chick tissues. As can be seen in Figure 6 (upper graph) in the transgenic liver extract, the amplification curves for human FSH cDNA began to rise at the 35th cycle, while no amplification was seen in the control chick liver. The amplification curve for 28S in both transgenic and control chicks began rising at the 25th cycle of the PCR. Human FSH transgene expression was higher in the liver than in heart and skin (Fig. 6, lower graph) .
DISCUSSION
The data demonstrate that lipofection of p-DNA for both transgenes in conjunction with a restriction enzyme to sperm is a highly efficient method for the production of transfected sperm to produce transgenic offspring by direct AI. The protocol is distinguished by its simplicity since no special training or equipment is required to execute it and it can be used in animals, like the chicken, where micromanipulation is not feasible [15] .
The major consideration in producing transgenic animals is if the transgene is integrated to the host genome or is episomal. It was expected that the integration would be genomic since we have already shown that in lipofected REMI sperm the transgene is integrated into the genome as determined by Southern blot [5] . In this study, Southern blot analysis of the transgenic chicken DNA was used to demonstrate integration. Digestion with XbaI resulted in a product of 6 kbp that was recognized by the probe for eGFP. XbaI or the other restriction enzyme digestion of the transgenic chicken genome DNA should have yielded a fragment of length 4.7 kbp if the DNA was not integrated into genomic DNA, similar to that seen with digestion of the free p-eGFP. Therefore, the observed product of 6 kbp demonstrated integration of the transgene into chicken genomic DNA. Similarly, the combination of HindIII and NotI resulted in a free insert of 1.3 kbp, which indicated integration occurred. Restriction enzyme analysis therefore strongly indicated that only one copy of the eGFP was integrated in one specific site of the genome. The observation of only one site of integration suggests that there are a limited number of susceptible sites on the genome [15] .
Sperm-mediated gene transfer requires the exogenous DNA to breach a number of barriers. The sperm membrane generally prevents the transfer of DNA as it binds and immobilizes the DNA. DNA that does cross the sperm barrier is rarely integrated, but episomal transmission is possible as an extrachromosomal episome. Endogenous nucleases within the cytoplasm can result in a nonspecific, random integration of damaged fragments of DNA [16] . Finally, the DNA needs to find areas susceptible to integration, which are limited. It is possible that the DNA can be transcripted to mRNA, and endogenous RT-transcriptases [4] , in turn, can convert it to cDNA, but this a rare occurrence.
In the transfected sperm REMI protocol described here, the sperm membrane is bypassed using lipofection, and the liposomes provide protection against endogenous nucleases. The restriction enzyme in turn opens up a number of sites to produce ''sticky ends'' that are then suitable for integration. Lipofection alone in the absence of REMI can result in transgenes in chickens, but the success rate is low (2 out of 53; [17] ). In contrast, our protocol produced a high percentage of transgenic chickens, and the transgene was expressed through three generations. This is particularly important for the chicken, where the large amount of yolk does not allow for micromanipulation and transgenic chickens are produced by manipulation of the blastodermal cells [15] .
To demonstrate that the method was valid for DNA other than eGFP, p-hFSH of alpha and beta subunits, in addition to leader sequences, was lipofected into chicken sperm to produce chickens expressing the human FSH transgene. The PCR fragment product could not be produced naturally in nontransgenic chick, as the alpha and beta subunits and leader sequences are under the control of different genes. The sequencing of the PCR product found in the transgenic chickens indicated it was essentially completely homologous with p-hFSH. Furthermore, since a radioimmunoassayable hFSH was found in the blood of the transgenic chickens, it should be possible to produce a mammalian protein in the avian eggs.
Although the data presented are consistent with integration of the eGFP and human FSH sequences with the genome and subsequent expression of the protein by the cell apparatus, several of the observations made were not expected: (1) why was the expression of eGFP by the chicken cells lower than that seen in transgenic calves; (2) why was the copy number for human FSH in G 2 higher than in G 1 ; and (3) why did the expression of human FSH decrease with age.
Expression of eGFP by the Chicken Cells
In the transgenic chicken lymphocytes, about 30% of the cells expressed the eGFP. This can be compared to bovine transgenic lymphocytes, where the percentage was about 60% [5, 6] . The reason for the failure of the eGFP to be expressed in the FACS analysis in a higher percentage of the lymphocytes examined is not known. However, it could well be that the low percentage observed is due to the sensitivity of the assay. The limit of detection of eGFP (;30 lM) in fluorescence microscopy is equivalent to ;4000 cytoplasmic molecules per cell [18] , and many of the cells may express eGFP below this limit. Alternatively, it could be that the gene may insert in a locus that is activated differently in different lymphocyte types (e.g., mononuclear, polynuclear), or the lack of expression in some of the cells could be due to suppressive activity related to specific silent regions in the genome. Another factor may be that the lymphocytes are differentiated stem cells, and differentiating cells express the same gene differently as they differentiate, e.g., when bovine granulosa cells differentiate into corpora lutea cells, they essentially lose the ability to express the gene for aromatase [19, 20] .
Increase in Copy Number in Subsequent Generations
Using quantitative real-time PCR, it was demonstrated that the transgene copy number was significantly increased in the G 2 (produced by interbreeding between transgenic chickens) compared with G 1 . Copy number in the G 3 was at least equal to the number in the G 2 . This can be explained by the integration of plasmid DNA into more than one site in the presence of nonequal sites in the mating chickens of G 2 and G 3. Therefore, we hypothesize that the G 1 of transgenic chicks may have had one or more copies of transgene from the transfected sperm. Interbreeding between G 1 transgenic chickens would then lead to development of monozygotes or amplification of gene copy numbers in subsequent generations. More importantly, the increased copy number of the transgene in G 2 and G 3 inbred chickens supports our conclusion that true genomic integration occurred, as opposed to epigenesis. In case of epigenic transfection, the copy number of the transgene would have tended to be lowered (diluted) in the next generations.
Decrease in the Expression of Human FSH with Age
We demonstrated the presence of hFSH protein in the peripheral blood of the G 1 and G 2 . However, the level of the hormone in the blood declined to a low level after 1.5 yrs and became undetectable by 2 yr of age. The loss of transgene expression with aging may be related to time-dependent silencing of CMV promoters observed in in vivo models. In a gene therapy study, Löser et al. [21] demonstrated that the hybrid promoter consisting of a minimal CMV promoter and the enhancer II of hepatitis B virus became inactive with age. The reason for the shutdown of the CMV promoter was probably stimuli known to activate the transcription factor NFKB, which binds to four sites in the CMV promoter/ enhancer. NFKB is known to be activated by bacterial lipopolysaccharides, and it could well be that sporadic infections that occurred during the lifetime of the transgenic chicken could have been responsible for the silencing of the transfected gene with aging.
We conclude that exogenous DNA and restriction enzyme sperm lipofection is a highly efficient transfection procedure. We have demonstrated that lipofected sperm can then be used in AI to produce transgenic offspring. Transgenic chickens expressing both nonmammalian and mammalian genes were produced. The technique is not limited to the chicken, as transgenic cattle [5, 6] and equine embryos [22] carrying eGFP transgenes have also been produced.
